LF Verdonck

3.0k total citations
47 papers, 1.8k citations indexed

About

LF Verdonck is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, LF Verdonck has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 14 papers in Immunology and 13 papers in Genetics. Recurrent topics in LF Verdonck's work include Hematopoietic Stem Cell Transplantation (24 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). LF Verdonck is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). LF Verdonck collaborates with scholars based in Netherlands, Italy and United Kingdom. LF Verdonck's co-authors include AW Dekker, H K Nieuwenhuis, GC de Gast, HM Lokhorst, Evan J. Petersen, Anton Hagenbeek, Marinus H. J. van Oers, A Schattenberg, Bob Löwenberg and G.C. Mudde and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

LF Verdonck

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LF Verdonck Netherlands 25 1.0k 559 502 368 302 47 1.8k
M Carotenuto Italy 26 1.1k 1.0× 542 1.0× 680 1.4× 446 1.2× 250 0.8× 81 2.2k
Charles Linker United States 23 944 0.9× 339 0.6× 657 1.3× 241 0.7× 265 0.9× 58 2.1k
César O. Freytes United States 30 1.0k 1.0× 567 1.0× 830 1.7× 523 1.4× 189 0.6× 82 2.2k
Edward Kanfer United Kingdom 26 1.1k 1.1× 416 0.7× 477 1.0× 175 0.5× 206 0.7× 55 1.8k
Gwynn D. Long United States 23 1.2k 1.1× 542 1.0× 759 1.5× 487 1.3× 214 0.7× 83 2.0k
D Occhini Italy 28 1.4k 1.4× 453 0.8× 625 1.2× 199 0.5× 424 1.4× 63 2.1k
Diane Coso France 25 929 0.9× 309 0.6× 582 1.2× 376 1.0× 246 0.8× 78 1.7k
Lilian Reich United States 25 1.3k 1.3× 553 1.0× 585 1.2× 198 0.5× 103 0.3× 50 2.2k
N. K. C. Ramsay United States 26 1.1k 1.1× 424 0.8× 384 0.8× 100 0.3× 259 0.9× 37 1.8k
F R Appelbaum United States 25 2.2k 2.1× 655 1.2× 876 1.7× 408 1.1× 187 0.6× 47 3.0k

Countries citing papers authored by LF Verdonck

Since Specialization
Citations

This map shows the geographic impact of LF Verdonck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LF Verdonck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LF Verdonck more than expected).

Fields of papers citing papers by LF Verdonck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LF Verdonck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LF Verdonck. The network helps show where LF Verdonck may publish in the future.

Co-authorship network of co-authors of LF Verdonck

This figure shows the co-authorship network connecting the top 25 collaborators of LF Verdonck. A scholar is included among the top collaborators of LF Verdonck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LF Verdonck. LF Verdonck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorp, Suzanne van, Ellen Meijer, Niels W.C.J. van de Donk, et al.. (2007). Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced.. PubMed. 65(5). 178–84. 6 indexed citations
2.
Deenik, Wendy, Bronno van der Holt, G. Verhoef, et al.. (2006). High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study. Annals of Hematology. 86(2). 117–125. 5 indexed citations
3.
4.
Agthoven, Michel van, Carin A. Uyl‐de Groot, Pieter Sonneveld, et al.. (2002). Cost analysis of CHOP (‐like) chemotherapy regimens for patients with newly diagnosed aggressive non‐Hodgkin's lymphoma. European Journal Of Haematology. 69(4). 213–220. 9 indexed citations
5.
6.
Slaper‐Cortenbach, Ineke, H P E Borst, Hans van der Lelie, et al.. (1999). The depletion of T cells from haematopoietic stem cell transplants. Lara D. Veeken. 38(8). 751–754. 28 indexed citations
7.
Griend, René van der, et al.. (1999). Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 23(2). 195–197. 16 indexed citations
8.
Ossenkoppele, GJ, Bronno van der Holt, LF Verdonck, et al.. (1998). A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group.. Data Archiving and Networked Services (DANS). 1 indexed citations
9.
Ellerbroek, Pauline M., et al.. (1998). Oerskovia xanthineolytica: a new pathogen in bone marrow transplantation. Bone Marrow Transplantation. 22(5). 503–505. 26 indexed citations
10.
11.
Bos, Gerard M.J., Wim L.J. van Putten, Bronno van der Holt, et al.. (1998). For which patients with aggressive non-Hodgkin’s lymphoma is prophylaxis for central nervous system disease mandatory?. Annals of Oncology. 9(2). 191–194. 55 indexed citations
12.
Dekker, A. W., Mars B. vanʼt Veer, W Sizoo, et al.. (1997). Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.. Journal of Clinical Oncology. 15(2). 476–482. 49 indexed citations
13.
Verdonck, LF, HM Lokhorst, AW Dekker, H K Nieuwenhuis, & Evan J. Petersen. (1996). Graft-versus-myeloma effect in two cases. The Lancet. 347(9004). 800–801. 180 indexed citations
14.
Daenen, Simon, Bob Löwenberg, Pieter Sonneveld, et al.. (1994). Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON).. PubMed. 8(1). 6–10. 26 indexed citations
15.
16.
Verdonck, LF, et al.. (1991). Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood. 78(3). 844–848. 52 indexed citations
17.
18.
Verdonck, LF, et al.. (1990). A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood. 75(3). 776–780. 3 indexed citations
19.
Verdonck, LF, et al.. (1987). Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.. PubMed. 2(1). 73–8. 69 indexed citations
20.
Verdonck, LF, et al.. (1987). Depletion of T Cells from Bone Marrow Grafts with Soybean Agglutinin and Sheep Red Blood Cells for Prevention of Graft-Versus-Host Disease. Hämatologie und Bluttransfusion. 30. 563–566. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Carotenuto Breakdown of academic impact, for papers by Charles Linker Breakdown of academic impact, for papers by César O. Freytes Breakdown of academic impact, for papers by Edward Kanfer Breakdown of academic impact, for papers by Gwynn D. Long Breakdown of academic impact, for papers by D Occhini Breakdown of academic impact, for papers by Diane Coso Breakdown of academic impact, for papers by Lilian Reich Breakdown of academic impact, for papers by N. K. C. Ramsay Breakdown of academic impact, for papers by F R Appelbaum
Rankless by CCL
2026